Centinela Freeman Regional Medical Center, Memorial Campus
Inglewood, CA

Centinela Freeman Regional Medical Center, Memorial Campus (CFMC) is owned and operated by Tenet California, a wholly owned subsidiary of Tenet HealthCare Corporation. DFMH is a 358-bed acute care community hospital offering a wide array of greatly needed medical and surgical services. Tenet continues the hospital's almost 50-year mission of service to the Inglewood community since it acquired the facility in 2001. DFMH is grounded in the tradition and history of the sisters of St. Joseph of Carondelet, who founded the hospital and remain on the hospital campus in service to the hospital and community.

The Cancer Center at Centinela Freeman Regional Medical Center, Memorial Campus offers an array of inpatient, outpatient and supportive services. From diagnosis to treatment, DFMH has the capabilities to handle a broad range of cancer diagnosis.

Patient Population
Centinela Freeman Regional Medical Center, Memorial Campus is the primary provider of radiation oncology services to the community/service area and although within an urban environment, the next closest hospital with radiation oncology services to the community is 8 miles to the north, 7 miles to the south and 15 miles to the east: none lie to the west. In 2002, about 45 percent of CFMC's radiation oncology services were provided to African Americans and 45 percent were to Latinos. African Americans make up 6.7 percent and Latinos 32 percent of California's population respectively.

This institution was awarded a five-year grant from the National Cancer Institute. The project title is Urban Latino African American Cancer Disparities Project. Read an excerpt of the proposal below:

The Urban Latino-African American Cancer Disparity Project (ULAAC Disparities Project) links Daniel Freeman Memorial Hospital (DFMH), a community hospital in service of a high need/low resource urban community (45% Latino, 45% African American) with major research institutions: University of Southern California, University of California San Francisco, and RAND to create a permanent clinical trials infrastructure. This collaboration generates unprecedented opportunity to reduce disparities in access to radiation oncology, cancer prevention and translational research trials as well as demonstrate an intervention model with potential application to similar urban communities throughout the nation.

Equipment installed at this site: Full TELESYNERGY(R) system using off-the-shelf software on a Windows XP Workstation.